CUSIP
No. M8737E108
|
Page 2
of 7 Pages
|
1
|
NAME OF REPORTING
PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
SUN
PHARMACEUTICAL INDUSTRIES LTD.
|
|||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
o
(b)
x
|
|
||
3
|
SEC
USE ONLY
|
|||
4
|
SOURCE
OF FUNDS (See Instructions)
PF
|
|||
5
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
or 2(e)
|
o
|
||
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
The
Republic of India
|
|||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
18,143,927*
|
||
8
|
SHARED
VOTING POWER
0
|
|||
9
|
SOLE
DISPOSITIVE POWER
18,143,927
|
|||
10
|
SHARED
DISPOSITIVE POWER
0
|
|||
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
18,143,927
|
|||
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions)
|
o
|
||
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
41.95%**
|
|||
14
|
TYPE
OF REPORTING PERSON (See Instructions)
CO
|
CUSIP
No. M8737E108
|
Page 3
of 7 Pages
|
1
|
NAME OF REPORTING
PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
SUN
PHARMA GLOBAL INC.
|
|||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
o
(b)
x
|
|
||
3
|
SEC
USE ONLY
|
|||
4
|
SOURCE
OF FUNDS (See Instructions)
PF
|
|||
5
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
or 2(e)
|
o
|
||
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
The
British Virgin Islands
|
|||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
18,143,927*
|
||
8
|
SHARED
VOTING POWER
0
|
|||
9
|
SOLE
DISPOSITIVE POWER
18,143,927
|
|||
10
|
SHARED
DISPOSITIVE POWER
0
|
|||
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
18,143,927
|
|||
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions)
|
o
|
||
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
41.95%**
|
|||
14
|
TYPE
OF REPORTING PERSON (See Instructions)
CO
|
CUSIP
No. M8737E108
|
Page 4
of 7 Pages
|
1
|
NAME OF REPORTING
PERSONS
I.R.S.
IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY)
ALKALOIDA
CHEMICAL COMPANY EXCLUSIVE GROUP LTD
|
|||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
(a)
o
(b)
x
|
|
||
3
|
SEC
USE ONLY
|
|||
4
|
SOURCE
OF FUNDS (See Instructions)
PF
|
|||
5
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
or 2(e)
|
o
|
||
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
The
Republic of Hungary
|
|||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
18,085,427*
|
||
8
|
SHARED
VOTING POWER
0
|
|||
9
|
SOLE
DISPOSITIVE POWER
18,085,427
|
|||
10
|
SHARED
DISPOSITIVE POWER
0
|
|||
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
18,085,427
|
|||
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions)
|
o
|
||
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
41.82%**
|
|||
14
|
TYPE
OF REPORTING PERSON (See Instructions)
CO
|
|
Exhibit No.
|
Description
|
|
99.26
|
Presentation
regarding the Annual General Meeting of the Issuer’s shareholders
scheduled for December 31,
2009.
|
Dated:
|
|
December
15, 2009
|
SUN
PHARMACEUTICAL INDUSTRIES LTD.
|
/s/ Sudhir V. Valia | |
Signature
|
|
Mr. Sudhir V. Valia | |
Director | |
Name/Title | |
SUN
PHARMA GLOBAL, INC.
|
|
/s/ Harin Mehta | |
Signature | |
Mr. Harin Mehta | |
Director | |
Name/Title | |
ALKALOIDA
CHEMICAL COMPANY EXCLUSIVE
GROUP LIMITED.
|
|
/s/ Harin Mehta | |
Signature | |
Mr. Harin Mehta | |
Director | |
Name/Title
|
|
|
Exhibit No.
|
Description
|
|
99.26
|
Presentation
regarding the Annual General Meeting of the Issuer’s shareholders
scheduled for December 31,
2009.
|